ITEM 5.07 Submission of Matters to a Vote of Security Holders

International Stem Cell Corporation (the "Company") held its Annual Meeting of Stockholders on June 14, 2023. The stockholders considered two proposals, which are described in more detail in the Company's definitive proxy statement dated April 28, 2023.





Proposal 1:   Election of four directors to hold office until the 2024 Annual
Meeting:



  A. Directors elected by holders of Series D Preferred Stock:




                       FOR         WITHHELD
Andrey Semechkin     2,457,143             0
Russell Kern         2,457,143             0




     B.   Directors elected by holders of all shares of stock (including shares of
          preferred stock voting on an as-converted basis):




                       FOR         WITHHELD
Donald A. Wright     7,833,624        44,091
Paul V. Maier        7,834,844        42,871




Broker Non-Votes: none



All of the foregoing candidates were elected.

























  2

© Edgar Online, source Glimpses